Skip to main navigation Skip to search Skip to main content

Reply to Cobussen et al: Gentamicin in Patients With Severe Sepsis and Septic Shock in the ICU: A Benefit or a Burden? Reply

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

3 Downloads (Pure)
Original languageEnglish
Pages (from-to)874
Number of pages1
JournalClinical Infectious Diseases
Volume65
Issue number5
DOIs
Publication statusPublished - 1 Sept 2017

Keywords

  • Cohort Studies
  • Gentamicins
  • Humans
  • Prospective Studies
  • Sepsis
  • Shock, Septic

Cite this